Prostate cancer screening
Screening and Early Detection
Changes in screening recommendations can be confusing. Legacy Cancer Institute continues to recommend screening for prostate cancer. It's important to understand that not all prostate cancer tumors need treatment and that options include simple monitoring. If your doctor recommends treatment for your cancer, there are a range of possibilities to consider.
Read more about Legacy's screening recommendations.
Who should be screened?
Men age 40 years and older, with an anticipated lifespan of 10 or more years should discuss baseline screening with their doctor. The discussion should include the known risks and the possible benefits of screening tests. Men who wish to be screened for prostate cancer should have both a PSA test and a digital rectal exam (DRE).
What other factors come into play?
When making your decision, consider family history of prostate cancer, race, previous PSA test results, and results of any prior biopsies.
What else should be considered?
- The amount of serious prostate cancer detected with the PSA test is unknown
- A PSA test does not distinguish between slow-growing and more aggressive cancers
- A variety of factors can affect PSA levels including an enlarged prostate, infection, trauma and prostate cancer
- The PSA level is generally thought to be proportional to the risk of prostate cancer, the extent of the cancer, and the long-term outcomes after treatment of the cancer